Skip to main content
Terug
Watch Compare

PSYCHEMEDICS CORP

Datakwaliteit: 83%
PMDI
OTC Services Health Services
€ 2,40
€ 0,00 (0,00%)
6 months return
—
Momentum
Neutral
ROE
-33,27%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)-56,79%

Kwaliteit

Return on Equity
-33,27%
Onder sectorgemiddelde (-15,97%)
ROIC-24,11%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio1,59
Interest Coverage-72,81

Waardering

PE (TTM)
-6,63
Onder sectorgemiddelde (-1,17)
P/B Ratio2,27
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Generating 878.000,0 in free cash flow
18 consecutive years of dividends — reliable payer

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstverassingen

EPS
Reported Estimate
Q12014 Q22014 Q32014 Q42014
Reported € 0,15 € 0,16 € 0,17 € 0,13
Estimate € 0,12 € 0,03 € 0,12 € 0,08
Verrassing +25,00% +433,33% +41,67% +62,50%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -33,27% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -1,86 M
ROE -33,27% ROA -18,66%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 878.000,0
ROIC -24,11% FCF Growth (3Y) -56,79%

Safety

D/E: N/A · Current: 1,59
Debt / Equity N/A Current Ratio 1,59
Interest Coverage -72,81 Asset Turnover N/A
Working Capital 2,25 M Tangible Book Value 5,45 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) -8,04% Dividend Growth (5Y) -27,31%
Consecutive Div Years 18 yrs

Valuation

P/E: -6,63 · EV/EBITDA: N/A
P/E Ratio -6,63 Forward P/E N/A
P/B Ratio 2,27 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 7,11%
Market Cap 12,34 M Enterprise Value 10,94 M

Per Share

EPS: N/A · FCF/Share: 0,14
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0,14 OCF / Share 0,15
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: -47,18% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion -47,18%
SBC-Adj. FCF -347.000 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -1,86 M -4,15 M -1,08 M -665.000,0 -3,86 M
EPS (Diluted) — — -0,19 -0,12 -0,70
Gross Profit 7,10 M 8,41 M 9,29 M 10,26 M 4,89 M
Operating Income -1,89 M -2,92 M -1,08 M 209.000,0 -6,07 M
EBITDA — — — — —
R&D Expenses 749.000,0 1,14 M 1,33 M 1,13 M 1,28 M
SG&A Expenses — — — — —
D&A 1,10 M 1,70 M 2,40 M 2,70 M 2,60 M
Interest Expense 26.000,0 17.000,0 32.000,0 49.000,0 75.000,0
Income Tax -55.000,0 716.000,0 44.000,0 -156.000,0 -2,35 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 8,32 M 12,33 M 18,73 M 21,55 M 24,00 M
Total Liabilities 3,19 M 5,65 M 7,96 M 9,31 M 11,49 M
Shareholders' Equity 5,13 M 6,67 M 10,77 M 12,24 M 12,51 M
Total Debt — 0,0 305.000,0 599.000,0 3,44 M
Cash & Equivalents 1,42 M 1,96 M 4,75 M 1,99 M 2,83 M
Current Assets 4,94 M 6,81 M 9,96 M 10,29 M 9,60 M
Current Liabilities 2,71 M 4,71 M 5,72 M 5,83 M 3,94 M

Sectorvergelijking

vs Services sector mediaan (615 peers)
Metriek Aandeel Sector Mediaan
P/E -6,6 -1,2
P/B 2,3 1,4
ROE % -33,3 -16,0
Net Margin % — -18,7
Rev Growth 5Y % — 4,0
D/E — 0,4

Dividendgeschiedenis

Recente betalingen per aandeel (nieuwste eerst).

Ex-dividend Betaling Bedrag / aandeel
May 24, 2023 — € 0,07
Mar 30, 2023 — € 0,07
Dec 01, 2022 — € 0,07
Aug 23, 2022 — € 0,07
May 26, 2022 — € 0,07
Dec 17, 2021 — € 0,05
Feb 20, 2020 — € 0,18
Nov 04, 2019 — € 0,18
Aug 05, 2019 — € 0,18
May 06, 2019 — € 0,18
Mar 13, 2019 — € 0,18
Nov 01, 2018 — € 0,18